Found: 41
Select item for more details and to access through your institution.
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 12, p. 3090, doi. 10.1210/clinem/dgad394
- By:
- Publication type:
- Article
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 10, p. 2569, doi. 10.1210/clinem/dgad183
- By:
- Publication type:
- Article
Response to Letter to the Editor From Chatelain et al: 'Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial'.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. e647, doi. 10.1210/clinem/dgad095
- By:
- Publication type:
- Article
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. 3378, doi. 10.1210/clinem/dgac513
- By:
- Publication type:
- Article
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children With GHD: 3-year Results From REAL 3.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. 1357, doi. 10.1210/clinem/dgab928
- By:
- Publication type:
- Article
Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 2, p. e888, doi. 10.1210/clinem/dgab736
- By:
- Publication type:
- Article
Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once- Weekly Somapacitan.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 2, p. 567, doi. 10.1210/clinem/dgaa775
- By:
- Publication type:
- Article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 4, p. e1358, doi. 10.1210/clinem/dgaa049
- By:
- Publication type:
- Article
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 4, p. e1847, doi. 10.1210/clinem/dgz310
- By:
- Publication type:
- Article
No effect of growth hormone administration on substrate oxidation during exercise in young, lean men.
- Published in:
- Journal of Physiology, 2005, v. 567, n. 3, p. 1035, doi. 10.1113/jphysiol.2005.089524
- By:
- Publication type:
- Article
Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Reversible Albumin-Binding Growth Hormone Derivative is Well Tolerated and Possesses a Potential Once-Weekly Treatment Profile.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Pegylated Long-Acting Human Growth Hormone Is Well-Tolerated in Healthy Subjects and Possesses a Potential Once-Weekly Pharmacokinetic and Pharmacodynamic Treatment Profile.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 7, p. 3411, doi. 10.1210/jc.2009-2813
- By:
- Publication type:
- Article
Acute Growth Hormone Administration Causes Exaggerated Increases in Plasma Lactate and Glycerol during Moderate to High Intensity Bicycling in Trained Young Men.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 11, p. 4966, doi. 10.1210/jc.2001-011797
- By:
- Publication type:
- Article
Dose Dependency of the Pharmacokinetics and Acute Lipolytic Actions of Growth Hormone.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 10, p. 4691, doi. 10.1210/jc.2002-020563
- By:
- Publication type:
- Article
GH Administration Changes Myosin Heavy Chain Isoforms in Skeletal Muscle But Does Not Augment Muscle Strength or Hypertrophy, Either Alone or Combined with Resistance Exercise Training in Healthy Elderly Men.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 2, p. 513, doi. 10.1210/jcem.87.2.8206
- By:
- Publication type:
- Article
The Acid-Labile Subunit of Human Ternary Insulin-Like Growth Factor Binding Protein Complex in Serum: Hepatosplanchnic Release, Diurnal Variation, Circulating Concentrations in Healthy Subjects...
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 12, p. 4408, doi. 10.1210/jcem.83.12.5311
- By:
- Publication type:
- Article
Serum Growth Hormone-Binding Protein in Obesity: Effect of a Short-Term, Very Low Calorie Diet and Diet-Induced Weight Loss.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 4, p. 1519, doi. 10.1210/jc.81.4.1519
- By:
- Publication type:
- Article
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
- Published in:
- Pituitary, 2023, v. 26, n. 1, p. 57, doi. 10.1007/s11102-022-01283-3
- By:
- Publication type:
- Article
Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
- Published in:
- European Journal of Endocrinology, 2022, v. 187, n. 1, p. 27, doi. 10.1530/EJE-21-1167
- By:
- Publication type:
- Article
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.
- Published in:
- European Journal of Endocrinology, 2018, v. 178, n. 5, p. 491, doi. 10.1530/EJE-17-1073
- By:
- Publication type:
- Article
Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1–4, and IGFBPs-1–3 protease activity in obese subjects.
- Published in:
- European Journal of Endocrinology, 2006, v. 155, n. 4, p. 575, doi. 10.1530/eje.1.02246
- By:
- Publication type:
- Article
Impact of adult growth hormone deficiency on daily functioning and well-being.
- Published in:
- BMC Research Notes, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-0500-7-813
- By:
- Publication type:
- Article
Cover Image, Volume 100, Number 4, April 2024.
- Published in:
- Clinical Endocrinology, 2024, v. 100, n. 4, p. i, doi. 10.1111/cen.15113
- By:
- Publication type:
- Article
Effective growth hormone replacement with once‐weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial.
- Published in:
- Clinical Endocrinology, 2024, v. 100, n. 4, p. 389, doi. 10.1111/cen.15025
- By:
- Publication type:
- Article
Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis.
- Published in:
- Journal of Physiology, 2010, v. 588, n. 2, p. 341, doi. 10.1113/jphysiol.2009.179325
- By:
- Publication type:
- Article
Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1015, doi. 10.1007/s40262-024-01395-y
- By:
- Publication type:
- Article
Effect of Kidney or Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Somapacitan: Two Open-Label, Parallel-Group Trials.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 8, p. 1015, doi. 10.1007/s40262-021-00990-7
- By:
- Publication type:
- Article
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin<sup>®</sup> in Children and Adults.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 9, p. 1217, doi. 10.1007/s40262-021-01011-3
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Understanding burden of illness for child growth hormone deficiency.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Normal Sweat Secretion Despite Impaired Growth Hormone-Insulin-Like Growth Factor-I Axis in Obese Subjects.
- Published in:
- International Journal of Endocrinology, 2011, p. 1, doi. 10.1155/2011/493840
- By:
- Publication type:
- Article
Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once‐weekly somapacitan or daily growth hormone.
- Published in:
- Clinical Endocrinology, 2020, v. 93, n. 5, p. 620, doi. 10.1111/cen.14273
- By:
- Publication type:
- Article
Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.
- Published in:
- Clinical Endocrinology, 2017, v. 87, n. 4, p. 350, doi. 10.1111/cen.13409
- By:
- Publication type:
- Article
Cover Image, Volume 87, Issue 4.
- Published in:
- Clinical Endocrinology, 2017, v. 87, n. 4, p. i, doi. 10.1111/cen.13471
- By:
- Publication type:
- Article
Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile M.H. Rasmussen et al. Tolerability, PK and IGF-I response of a long-acting GH.
- Published in:
- Clinical Endocrinology, 2010, v. 73, n. 6, p. 769, doi. 10.1111/j.1365-2265.2010.03863.x
- By:
- Publication type:
- Article
GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake.
- Published in:
- Clinical Endocrinology, 2001, v. 55, n. 1, p. 77, doi. 10.1046/j.1365-2265.2001.01344.x
- By:
- Publication type:
- Article